Angel News

Back to Homepage

27th March 2018

Renephra secures £231k from Deepbridge & Catapult

Renephra, a medical device company, today announced that it has raised £231,000 from Deepbridge Capital and the GM&C Life Sciences Fund, managed by Catapult Ventures.

Renephra, spun out of The University of Manchester and Manchester University NHS Foundation Trust by UMI3 Ltd, is developing an innovative medical device to treat patients with chronic oedema and fluid overload. Renephra's Transdermal Fluid Removal (TFR) technology enables the extraction of excess fluid through the skin using disposable microneedle patches and overcomes many of the issues with current treatments.


Register / Login now to read full story

In order to read the full story we need you to be registered with us, please click the links below to login or register.

Login / Register

Add a comment:




Enter the characters in the image shown:

Back to Homepage